New syrup could ease wheezing in children with bronchitis
NCT ID NCT06411925
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a syrup called Atock Dry Syrup can reduce wheezing in children aged 6 months to 12 years with acute bronchitis. About 296 kids will receive either the syrup or a standard patch treatment. The main goal is to see if wheezing improves within 3 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Atock Dry Syrup (active ingredient not specified in lay terms; likely a bronchodilator or antitussive)
What this could lead to
If it works, this could provide a new, easy-to-take syrup option for relieving wheezing in children with acute bronchitis.
What could go wrong
This is a late-stage trial but compares two existing treatments, so the new syrup may not be better than the patch. Also, results may not apply to children with chronic lung conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE BRONCHITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Soonchunhyang University Seoul Hospital
RECRUITINGSeoul, South Korea
Contact